Viewing nowCombinationHyuniz Valsartan Tablet 5/80mg (Amlodipine, Valsartan)
Valsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Huons Meditech Co., Ltd.

MFDS item code 201503875 · Approved 2015.06.15 · Insurance code 670401010
Treatment of essential hypertension not controlled with monotherapy
Patients may have essential hypertension that is not adequately controlled by monotherapy with amlodipine or valsartan. In this case, combining the two medications may be more effective for blood pressure control. Amlodipine dilates blood vessels to lower blood pressure, while valsartan blocks the action of substances that cause blood pressure to rise, stabilizing blood pressure. Using both medications together can more effectively improve blood pressure. Managing hypertension may reduce the risk of cardiovascular complications. This medication is used for the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, a direct switch to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance ≥10mL/min). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance <10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It is contraindicated in patients with hypersensitivity to this medication, pregnant or breastfeeding women, patients with severe renal or liver disease, or those with a history of certain heart diseases or vascular edema. In patients with insufficient fluid or sodium, hypotension may occur, so their condition should be corrected before administration and carefully monitored during treatment. Patients with high potassium levels or those taking medications that increase potassium should have their potassium levels monitored frequently. Patients with impaired kidney function or renal artery stenosis may have an increased risk of worsening kidney function, requiring careful observation. In patients with heart failure or after myocardial infarction, kidney function changes should be assessed carefully, and appropriate measures should be taken if blood pressure becomes too low. Dizziness or fatigue may occur while driving or operating machinery, requiring caution. When this medication is used in conjunction with other antihypertensives, the risks of hypotension, hyperkalemia, and worsening kidney function may increase, so blood pressure and kidney function should be monitored frequently as per the physician’s instructions. Patients with liver dysfunction may need dose adjustments, and overdose of this medication may produce symptoms such as hypotension, tachycardia, and shock, necessitating immediate medical attention. Safety in pediatric patients has not been sufficiently established, hence its use in those under 18 years of age is not recommended. For the elderly, a similar dosage to that of adults is recommended but may require caution depending on their condition. During the treatment with this medication, adverse reactions such as headache, dizziness, swelling, skin rash, gastrointestinal disturbances, etc., may occur; if symptoms are severe, consultation with a doctor is advised.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1°C and 30°C. This will help maintain the medication's effectiveness.
Dark yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Huons Meditech Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.